The Family Firm’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
The Family Firm's AMGN Position: Q2 2025 in Review
The Family Firm sold out of Amgen (AMGN) in Q2 2025, closing a stake of 643 shares — an estimated $200K sold.
The Family Firm first reported a position in AMGN in Q4 2014 and held it in 19 quarters. The position peaked at $331K in Q4 2022. 2,852 funds tracked by Wall St. Rank hold AMGN as of Q2 2025.
- The Family Firm reported no remaining Amgen position as of Q2 2025 after selling out during the quarter.
- The Family Firm sold 643 Amgen shares in Q2 2025, an estimated $200K.
- The Family Firm first reported a position in Amgen in Q4 2014 and held it in 19 quarters.
- The Family Firm's Amgen position peaked at $331K in Q4 2022.
- 2,852 funds tracked by Wall St. Rank held Amgen as of Q2 2025.
Based on The Family Firm's 13F filing for Q2 2025, filed 8 Aug 2025.